共 707 条
[1]
Lawson PA(2016)Reclassification of clostridium difficile as clostridioides difficile (Hall and O’Toole 1935) Prévot 1938 Anaerobe 40 95-99
[2]
Citron DM(2018)How to: surveillance of Clostridium difficile infections Clin Microbiol Infect 24 469-475
[3]
Tyrrell KL(2016)Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013 Eurosurveillance 21 30295-594
[4]
Finegold SM(2019)Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study Clin Microbiol Infect 25 588-536
[5]
Krutova M(2009)Clostridium difficile infection: new developments in epidemiology and pathogenesis Nat Rev Microbiol 7 526-206
[6]
Kinross P(2017)Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis Lancet Infect Dis 17 194-26
[7]
Barbut F(2014)Committee. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection Clin Microbiol Infect 20 1-e48
[8]
Hajdu A(2018)Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Clin Infect Dis 66 e1-462
[9]
Wilcox M(2018)Update of treatment algorithms for Clostridium difficile infection Clin Microbiol Infect 24 452-2855
[10]
Kuijper E(2011)A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection J Antimicrob Chemother 66 2850-e02718